BioMed Research International / 2015 / Article / Tab 2

Research Article

Clinical Impact of the KL-6 Concentration of Pancreatic Juice for Diagnosing Pancreatic Masses

Table 2

Diagnostic ability of PJC and/or KL-6 measurement of pancreatic juice for differentiating pancreatic malignancy from pancreatic inflammatory lesion and IPMN.

PDAC or IPMC () and IPMN or pancreatic inflammatory lesion ()
Sensitivity, %Specificity, %PPV, %NPV, %Accuracy, %

KL-6 measurement79.564.573.871.472.9
(31/39)(20/31)(31/42)(20/28)(51/70)

PJC82.196.897.081.188.6
(32/39)(30/31)(32/33)(30/37)(62/70)

PJC and KL-6 measurement combined97.4a96.897.496.897.1b
(38/39)(30/31)(38/39)(30/31)(68/70)

Materials of which final diagnosis was obtained by operation or clinical follow-up.
compared with cytopathology alone.
compared with cytopathology alone.